{"id":31533,"date":"2026-02-13T09:42:15","date_gmt":"2026-02-13T12:42:15","guid":{"rendered":"https:\/\/sobelconsult.com\/mdr-and-ivdr-under-review\/"},"modified":"2026-02-13T09:42:52","modified_gmt":"2026-02-13T12:42:52","slug":"mdr-and-ivdr-under-review","status":"publish","type":"post","link":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/","title":{"rendered":"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais"},"content":{"rendered":"\n

Nos \u00faltimos meses, o setor regulat\u00f3rio tem se concentrado cada vez mais em t\u00f3picos relacionados a MDR e IVDR.<\/p>\n\n

Na \u00faltima edi\u00e7\u00e3o da Sobel News, abordamos um estudo encomendado pela Uni\u00e3o Europeia que analisa o impacto do MDR e do IVDR<\/a> no mercado de dispositivos m\u00e9dicos da regi\u00e3o.<\/p>\n\n

Agora, no final de janeiro, Bruxelas sediou discuss\u00f5es sobre poss\u00edveis revis\u00f5es do MDR e do IVDR.<\/strong><\/p>\n\n

Essa atualiza\u00e7\u00e3o, juntamente com importantes desenvolvimentos regulat\u00f3rios nos Estados Unidos e na China, \u00e9 o foco deste artigo.<\/p>\n\n

MDR e IVDR em an\u00e1lise na Uni\u00e3o Europeia<\/strong><\/h2>\n\n

As autoridades regulat\u00f3rias da Uni\u00e3o Europeia apresentaram propostas iniciais para revisar o MDR e o IVDR<\/strong><\/a> (Regulamenta\u00e7\u00e3o de Dispositivos M\u00e9dicos e Regulamenta\u00e7\u00e3o de Diagn\u00f3stico In Vitro).<\/p>\n\n

O objetivo \u00e9 ajustar as opera\u00e7\u00f5es regulat\u00f3rias para reduzir os desafios enfrentados pelos fabricantes durante os processos de certifica\u00e7\u00e3o e manuten\u00e7\u00e3o.<\/p>\n\n

As discuss\u00f5es incluem melhorias na previsibilidade regulat\u00f3ria e poss\u00edveis extens\u00f5es de cronograma em situa\u00e7\u00f5es espec\u00edficas. Elas tamb\u00e9m abordam ajustes de requisitos que afetam a disponibilidade de produtos no mercado europeu. <\/p>\n\n

Desde sua implementa\u00e7\u00e3o, o MDR e o IVDR aumentaram significativamente os requisitos t\u00e9cnicos e de documenta\u00e7\u00e3o para os fabricantes, fortalecendo os padr\u00f5es de seguran\u00e7a e desempenho.<\/p>\n\n

No entanto, essa estrutura introduziu desafios, incluindo o aumento dos custos regulat\u00f3rios, a complexidade do processo e a capacidade limitada dos \u00f3rg\u00e3os notificados.<\/p>\n\n

Basicamente, as revis\u00f5es propostas visam melhorar a efici\u00eancia regulat\u00f3ria sem comprometer os objetivos principais.<\/p>\n\n

Para os fabricantes, as mudan\u00e7as no MDR e no IVDR podem afetar o planejamento regulat\u00f3rio, as prioridades de mercado e os cronogramas do ciclo de vida do produto.<\/p>\n\n

Espera-se que esse t\u00f3pico permane\u00e7a altamente relevante nos pr\u00f3ximos meses.<\/p>\n\n

O QMSR<\/strong>entra em vigor nos Estados Unidos<\/strong><\/h2>\n\n

A O novo Regulamento do Sistema de Gerenciamento de Qualidade (QMSR) da FDA entrou em vigor,<\/strong><\/a> alinhando os requisitos do sistema de qualidade de dispositivos m\u00e9dicos com a ISO 13485.<\/p>\n\n

A atualiza\u00e7\u00e3o representa um passo importante em dire\u00e7\u00e3o \u00e0 harmoniza\u00e7\u00e3o regulat\u00f3ria internacional.<\/p>\n\n

Na pr\u00e1tica, ela introduz ajustes relevantes nas expectativas de conformidade dos fabricantes que operam no mercado dos EUA, exigindo <\/strong>atualiza\u00e7\u00f5es nos procedimentos internos, na documenta\u00e7\u00e3o e nos processos de auditoria.<\/strong><\/a><\/p>\n\n

\"Mãos<\/figure>\n\n

China lan\u00e7a plano para fortalecer os sistemas de qualidade no setor de cosm\u00e9ticos<\/strong><\/h2>\n\n

As autoridades reguladoras chinesas anunciaram um plano de a\u00e7\u00e3o para 2026-2028<\/a> com o objetivo de fortalecer os sistemas de qualidade dos fabricantes de cosm\u00e9ticos.<\/strong><\/p>\n\n

A iniciativa inclui uma supervis\u00e3o aprimorada baseada em riscos, um controle mais rigoroso das mat\u00e9rias-primas e o monitoramento cont\u00ednuo da conformidade durante todo o ciclo de vida do produto.<\/p>\n\n

Certamente, isso sinaliza um claro aumento nas expectativas regulat\u00f3rias para as empresas que fabricam ou exportam para o mercado chin\u00eas.<\/p>\n\n

FDA publica vers\u00e3o preliminar de orienta\u00e7\u00e3o para cosm\u00e9ticos<\/strong><\/h2>\n\n

A FDA divulgou um esbo\u00e7o de orienta\u00e7\u00e3o que descreve a seguran\u00e7a atualizada e as expectativas regulat\u00f3rias<\/strong><\/a> aplic\u00e1veis aos produtos cosm\u00e9ticos.<\/strong><\/p>\n\n

O documento refor\u00e7a a necessidade de documenta\u00e7\u00e3o t\u00e9cnica robusta, manuten\u00e7\u00e3o de registros adequados e pr\u00e1ticas de monitoramento p\u00f3s-comercializa\u00e7\u00e3o refor\u00e7adas.<\/strong><\/p>\n\n

Embora ainda preliminar, a orienta\u00e7\u00e3o indica a futura dire\u00e7\u00e3o regulamentar e permite que as empresas iniciem ajustes antecipados em seus processos de conformidade.<\/p>\n\n

Qualidade, rastreabilidade e supervis\u00e3o regulat\u00f3ria<\/strong><\/h2>\n\n

As discuss\u00f5es em torno do MDR e do IVDR, combinadas com a implementa\u00e7\u00e3o do QMSR nos Estados Unidos e as novas iniciativas regulat\u00f3rias na China e no setor de cosm\u00e9ticos dos EUA, demonstram que o ambiente regulat\u00f3rio global continua a avan\u00e7ar em dire\u00e7\u00e3o a modelos mais fortes de qualidade, rastreabilidade e supervis\u00e3o.<\/p>\n\n

Para fabricantes e empresas com atua\u00e7\u00e3o internacional, monitorar essas mudan\u00e7as e integrar a intelig\u00eancia regulat\u00f3ria \u00e0 estrat\u00e9gia de neg\u00f3cios \u00e9 essencial para reduzir riscos, manter a conformidade e sustentar a competitividade em mercados cada vez mais exigentes.<\/p>\n\n

N\u00e3o importa se o t\u00f3pico \u00e9 MDR e IVDR, tend\u00eancias regulat\u00f3rias de cosm\u00e9ticos ou novas publica\u00e7\u00f5es de autoridades regulat\u00f3rias, o boletim informativo da Sobel \u00e9 onde voc\u00ea encontrar\u00e1 as atualiza\u00e7\u00f5es mais importantes do setor.<\/p>\n\n

Assine gratuitamente o Sobel News Round Up<\/a> e mantenha-se informado sobre os acontecimentos que podem afetar sua empresa nos setores de dispositivos m\u00e9dicos, IVD e cosm\u00e9ticos.<\/p>\n\n

Para criar uma estrat\u00e9gia regulat\u00f3ria bem-sucedida, voc\u00ea precisa estar preparado para as atualiza\u00e7\u00f5es regulat\u00f3rias globais cont\u00ednuas.<\/p>\n","protected":false},"excerpt":{"rendered":"

Atualiza\u00e7\u00f5es globais sobre MDR e IVDR, o QMSR nos EUA e novos requisitos regulat\u00f3rios para cosm\u00e9ticos na China e no mercado dos EUA.<\/p>\n","protected":false},"author":16,"featured_media":31528,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[308],"tags":[297,329,127,142,128,156,309],"class_list":["post-31533","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-pt-br","tag-brasil","tag-china-pt-br","tag-cosmeticos-pt-br","tag-dispositivos-medicos","tag-europa-pt-br","tag-fda-pt-br","tag-noticias-pt-br"],"yoast_head":"\nNot\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais - Sobel<\/title>\n<meta name=\"description\" content=\"Atualiza\u00e7\u00f5es globais sobre MDR e IVDR, o QMSR nos EUA e novos requisitos regulat\u00f3rios para cosm\u00e9ticos na China e no mercado dos EUA.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais\" \/>\n<meta property=\"og:description\" content=\"Atualiza\u00e7\u00f5es globais sobre MDR e IVDR, o QMSR nos EUA e novos requisitos regulat\u00f3rios para cosm\u00e9ticos na China e no mercado dos EUA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/\" \/>\n<meta property=\"og:site_name\" content=\"Sobel\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-13T12:42:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-13T12:42:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Bruna Marzarotto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bruna Marzarotto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/\"},\"author\":{\"name\":\"Bruna Marzarotto\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/bd2753d272a36eb353492e956e803d3b\"},\"headline\":\"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais\",\"datePublished\":\"2026-02-13T12:42:15+00:00\",\"dateModified\":\"2026-02-13T12:42:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/\"},\"wordCount\":792,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#organization\"},\"image\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp\",\"keywords\":[\"Brasil\",\"China\",\"Cosm\u00e9ticos\",\"Dispositivos m\u00e9dicos\",\"Europa\",\"FDA\",\"Not\u00edcias\"],\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/\",\"url\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/\",\"name\":\"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais - Sobel\",\"isPartOf\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp\",\"datePublished\":\"2026-02-13T12:42:15+00:00\",\"dateModified\":\"2026-02-13T12:42:52+00:00\",\"description\":\"Atualiza\u00e7\u00f5es globais sobre MDR e IVDR, o QMSR nos EUA e novos requisitos regulat\u00f3rios para cosm\u00e9ticos na China e no mercado dos EUA.\",\"breadcrumb\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#primaryimage\",\"url\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp\",\"contentUrl\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp\",\"width\":1500,\"height\":1000,\"caption\":\"Rear view of female business executive giving a speech. MDR and IVDR,\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sobelconsult.com\/pt-br\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#website\",\"url\":\"https:\/\/sobelconsult.com\/pt-br\/\",\"name\":\"Sobel\",\"description\":\"Regulatory Consultancy\",\"publisher\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sobelconsult.com\/pt-br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#organization\",\"name\":\"Sobel\",\"url\":\"https:\/\/sobelconsult.com\/pt-br\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.png\",\"contentUrl\":\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.png\",\"width\":741,\"height\":290,\"caption\":\"Sobel\"},\"image\":{\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/bd2753d272a36eb353492e956e803d3b\",\"name\":\"Bruna Marzarotto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0739b908e11e6bd3813c8c44709242bf98c50500b85aa4103b34b62b248ec195?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0739b908e11e6bd3813c8c44709242bf98c50500b85aa4103b34b62b248ec195?s=96&d=mm&r=g\",\"caption\":\"Bruna Marzarotto\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais - Sobel","description":"Atualiza\u00e7\u00f5es globais sobre MDR e IVDR, o QMSR nos EUA e novos requisitos regulat\u00f3rios para cosm\u00e9ticos na China e no mercado dos EUA.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/","og_locale":"pt_BR","og_type":"article","og_title":"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais","og_description":"Atualiza\u00e7\u00f5es globais sobre MDR e IVDR, o QMSR nos EUA e novos requisitos regulat\u00f3rios para cosm\u00e9ticos na China e no mercado dos EUA.","og_url":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/","og_site_name":"Sobel","article_published_time":"2026-02-13T12:42:15+00:00","article_modified_time":"2026-02-13T12:42:52+00:00","og_image":[{"width":1500,"height":1000,"url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp","type":"image\/webp"}],"author":"Bruna Marzarotto","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Bruna Marzarotto","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#article","isPartOf":{"@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/"},"author":{"name":"Bruna Marzarotto","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/bd2753d272a36eb353492e956e803d3b"},"headline":"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais","datePublished":"2026-02-13T12:42:15+00:00","dateModified":"2026-02-13T12:42:52+00:00","mainEntityOfPage":{"@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/"},"wordCount":792,"commentCount":0,"publisher":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#organization"},"image":{"@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#primaryimage"},"thumbnailUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp","keywords":["Brasil","China","Cosm\u00e9ticos","Dispositivos m\u00e9dicos","Europa","FDA","Not\u00edcias"],"articleSection":["Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/","url":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/","name":"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais - Sobel","isPartOf":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#primaryimage"},"image":{"@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#primaryimage"},"thumbnailUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp","datePublished":"2026-02-13T12:42:15+00:00","dateModified":"2026-02-13T12:42:52+00:00","description":"Atualiza\u00e7\u00f5es globais sobre MDR e IVDR, o QMSR nos EUA e novos requisitos regulat\u00f3rios para cosm\u00e9ticos na China e no mercado dos EUA.","breadcrumb":{"@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#primaryimage","url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp","contentUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/02\/Rear-view-of-female-business-executive-giving-a-speech.webp","width":1500,"height":1000,"caption":"Rear view of female business executive giving a speech. MDR and IVDR,"},{"@type":"BreadcrumbList","@id":"https:\/\/sobelconsult.com\/pt-br\/mdr-and-ivdr-under-review\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sobelconsult.com\/pt-br\/home\/"},{"@type":"ListItem","position":2,"name":"Not\u00edcias: MDR e IVDR em revis\u00e3o, QMSR em vigor e muito mais"}]},{"@type":"WebSite","@id":"https:\/\/sobelconsult.com\/pt-br\/#website","url":"https:\/\/sobelconsult.com\/pt-br\/","name":"Sobel","description":"Regulatory Consultancy","publisher":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sobelconsult.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sobelconsult.com\/pt-br\/#organization","name":"Sobel","url":"https:\/\/sobelconsult.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.png","contentUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.png","width":741,"height":290,"caption":"Sobel"},"image":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/bd2753d272a36eb353492e956e803d3b","name":"Bruna Marzarotto","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0739b908e11e6bd3813c8c44709242bf98c50500b85aa4103b34b62b248ec195?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0739b908e11e6bd3813c8c44709242bf98c50500b85aa4103b34b62b248ec195?s=96&d=mm&r=g","caption":"Bruna Marzarotto"}}]}},"_links":{"self":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts\/31533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/comments?post=31533"}],"version-history":[{"count":1,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts\/31533\/revisions"}],"predecessor-version":[{"id":31534,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts\/31533\/revisions\/31534"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/media\/31528"}],"wp:attachment":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/media?parent=31533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/categories?post=31533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/tags?post=31533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}